Table 8.
Reference | Authors | Year | Patient Group | Study Findings in Diseased Group vs. Control |
---|---|---|---|---|
[144] | Jiang et al. | 2017 | 52 with ESKD vs. 60 healthy |
|
[19] | Xu et al. | 2017 | 32 CKD vs.32 healthy |
|
[145] | Salgado et al. | 2016 | Pediatric patients; 8 on peritoneal dialysis, 8 hemodialysis 10 post kidney transplants vs. 13 healthy |
|
[140] | Jiang et al. | 2016 | 65 CKD (Stage 1–5) vs. 20 healthy |
|
[133] | Yang et al. | 2015 | 7 Hypertensive patients vs. 10 healthy |
|
[146] | Wong et al. | 2014 | 24 patients with ESKD undergoing hemodialysis vs. 12 healthy |
|
[134] | Vaziri et al. | 2013 | 24 patients with ESKD undergoing hemodialysis vs. 12 healthy |
|
[147] | I. Wang et al. | 2012 | 29 patients with ESKD undergoing PD vs. 41 healthy |
|
[148] | Wang et al. | 2012 | 30 patients with ESKD not on dialysis vs. 10 healthy |
|
[141] | Ranganathan et al. | 2009 | 13 patients with CKD (Stage 3 and 4) |
|
[142] | Fukuuchi et al. | 2002 | 27 patients with chronic kidney failure and 20 patients with hemodialysis vs. 12 healthy controls |
|
[143] | Hida et al. | 1996 | ESKD patients 20 with hemodialysis vs. 12 healthy controls |
|